IOVA - Iovance Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

IOVA is currently covered by 13 analysts with an average potential upside of $14.62 (117.36%) backed by displayed 120 price targets and 153 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.91% with an average time for these price targets to be met of 128.69 days.

Highest price target for IOVA is 25, Lowest price target is 5, average price target is 15.

Most recent stock forecast was given by PETER LAWSON from BARCLAYS on 18-Sep-2023. First documented stock forecast 04-Aug-2017.

Currently, out of the existing stock ratings of IOVA - 55 which are a Buy (90.16%), 6 which are a Hold (9.84%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

18

$13.5 (300.00%)

40

10 days ago

3/6 (50%)

$10.59 (70.91%)

105

Buy

25

$20.5 (455.56%)

25

13 days ago

8/14 (57.14%)

$11.49 (117.15%)

97

Buy

18

$13.5 (300.00%)

18

13 days ago

2/10 (20%)

$11.82 (118.46%)

54

Buy

17

$12.5 (277.78%)

17

13 days ago

0/7 (0%)

$15.3 (124.67%)

Buy

30

$25.5 (566.67%)

30

13 days ago

0/7 (0%)

$22.91 (193.09%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IOVA (Iovance Biotherapeutics) average time for price targets to be met?

On average it took 128.69 days on average for the stock forecasts to be realized with a an average price target met ratio 42.91

Which analyst has the current highest performing score on IOVA (Iovance Biotherapeutics) with a proven track record?

GEULAH LIVSHITS

Which analyst has the most public recommendations on IOVA (Iovance Biotherapeutics)?

Geulah Livshits works at CHARDAN CAPITAL and has 3 price targets and 2 ratings on IOVA

Which analyst is the currently most bullish on IOVA (Iovance Biotherapeutics)?

Biren Amin with highest potential upside - $38.5

Which analyst is the currently most reserved on IOVA (Iovance Biotherapeutics)?

Madhu Kumar with lowest potential downside - $1.5

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart